Literature DB >> 20949458

Neutrophil phagocytosis by tumor cells--a cytological study.

Niti Singhal1, Uma Handa, Cherry Bansal, Harsh Mohan.   

Abstract

Cell cannibalism is defined as the ability of a cell to phagocytose another cell. Malignant tumor cells may develop phagocytic property and demonstrate phagocytosis of own cells or cells of other series like neutrophils and lymphocytes. We report 11 cases in which the tumor cells showed evidence of neutrophil phagocytosis/emperipolesis on FNAC smears. Cases of malignancies diagnosed on FNA over a period of 1 year were retrieved, and smears were examined for neutrophil phagocytosis by tumor cells. These cases were classified according to type and differentiation of malignancy. The cytomorphological features and background inflammation were also studied at both primary and metastatic site. Of 362 malignant cases diagnosed on FNA smears, in 11 cases (3.09%), tumor cells showed neutrophil phagocytosis. The background showed increase in polymorphs in all cases. All the cases were associated with metastasis at presentation and were high-grade tumors cytologically. There were three cases of anaplastic carcinoma, two cases of adenocarcinoma, two cases of carcinoma breast, two cases of anaplastic non-Hodgkins lymphoma, one case each of squamous cell carcinoma and small cell carcinoma from larynx and lung, respectively. Phagocytic activity by tumor cells is uncommon and usually seen in high-grade/poorly differentiated malignancies. It is frequently associated with metastatic disease. On cytology smears, true phagocytosis of neutrophils by tumor cells has to be distinguished from superimposed inflammatory cells from the background. The tumor cells also need to be distinguished from histiocytes displaying phagocytosis.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20949458     DOI: 10.1002/dc.21421

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  8 in total

1.  Unusual sites of Rosai-Dorfman disease in children: 5 years experience from tertiary care paediatric haemato-oncology centre.

Authors:  Janani Arul; Riya Kataria; Varsha Kolli; Arunan Murali; Gramani Arumugam Vasugi; Arathi Srinivasan
Journal:  Sudan J Paediatr       Date:  2022

2.  Salivary duct carcinoma with striking neutrophil-tumor cell cannibalism.

Authors:  Payam Arya; Walid E Khalbuss; Sara E Monaco; Liron Pantanowitz
Journal:  Cytojournal       Date:  2011-08-24       Impact factor: 2.091

3.  Nano-hole induction by nanodiamond and nanoplatinum liquid, DPV576, reverses multidrug resistance in human myeloid leukemia (HL60/AR).

Authors:  Alia Ghoneum; Shivani Sharma; James Gimzewski
Journal:  Int J Nanomedicine       Date:  2013-07-19

4.  Pleiotropic effects of 4-hydroxynonenal on oxidative burst and phagocytosis in neutrophils.

Authors:  Balu K Chacko; Stephanie B Wall; Philip A Kramer; Saranya Ravi; Tanecia Mitchell; Michelle S Johnson; Landon Wilson; Stephen Barnes; Aimee Landar; Victor M Darley-Usmar
Journal:  Redox Biol       Date:  2016-06-23       Impact factor: 11.799

5.  Heterotypic neutrophil-in-tumor structure: A novel pathological feature first discovered in the tissues of OPSCC.

Authors:  Jie Fan; Peng Li; Qigen Fang; Yang Yang; He Zhang; Wei Du; Shanting Liu; Ruihua Luo
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

6.  Apoptotic effect of a novel kefir product, PFT, on multidrug-resistant myeloid leukemia cells via a hole-piercing mechanism.

Authors:  Mamdooh Ghoneum; James Gimzewski
Journal:  Int J Oncol       Date:  2014-01-15       Impact factor: 5.650

7.  Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature.

Authors:  R C Maia; E de Meis; S Romano; J A Dobbin; C E Klumb
Journal:  Braz J Med Biol Res       Date:  2014-10-10       Impact factor: 2.590

8.  Role of Heterotypic Neutrophil-in-Tumor Structure in the Prognosis of Patients With Buccal Mucosa Squamous Cell Carcinoma.

Authors:  Jie Fan; Qigen Fang; Yang Yang; Meng Cui; Ming Zhao; Jinxing Qi; Ruihua Luo; Wei Du; Shanting Liu; Qiang Sun
Journal:  Front Oncol       Date:  2020-10-15       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.